Introducing Chromatography-Free Mass Spectrometry With Arnd Ingendoh

The Technology Networks team attended ASMS 2025 and spoke with Arnd Ingendoh, Vice President, Business Development, Bruker Applied MS and Co-Managing Director, RECIPE. He discussed the current limitations of traditional LC-MS/MS assays, such as low sample throughput and the significant time and expertise required to perform them. However, he highlighted how emerging technologies that eliminate the chromatography step in clinical assays are showing promising results. Comparative studies using previously analyzed LC-MS/MS samples suggest that these new approaches can deliver accurate results with greater efficiency.

Watch the full video to learn more about the advantages of chromatography-free mass spectrometry.